Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Schizophrenia

  Free Subscription


24.06.2019

2 Biol Psychiatry
1 Cereb Cortex
2 J Clin Psychopharmacol
1 Neuropsychopharmacology
1 Pharmacopsychiatry
5 Psychiatry Res
3 Schizophr Res


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Biol Psychiatry

  1. ROFFMAN JL
    B Vitamin Supplements in First-Episode Psychosis: Some Neurodevelopmental and Physiologic Context.
    Biol Psychiatry. 2019;86:4-6.
    PubMed     Text format    

  2. KHANDAKER GM
    Early-Life Biomarkers for Psychosis Risk in Young People: Another Nail in the Coffin for Cartesian Dualism.
    Biol Psychiatry. 2019;86:2-3.
    PubMed     Text format    


    Cereb Cortex

  3. KERMATH BA, Vanderplow AM, Cahill ME
    Dysregulated Prefrontal Cortical RhoA Signal Transduction in Bipolar Disorder with Psychosis: New Implications for Disease Pathophysiology.
    Cereb Cortex. 2019 Apr 11. pii: 5430489. doi: 10.1093.
    PubMed     Text format     Abstract available


    J Clin Psychopharmacol

  4. LACHANCE A, Corbeil O, Corbeil S, Chalifour G, et al
    Case Reports of Aripiprazole and Problematic Gambling in Schizophrenia: A Critical Review of the Evidence.
    J Clin Psychopharmacol. 2019 Jun 14. doi: 10.1097/JCP.0000000000001068.
    PubMed     Text format     Abstract available

  5. DEMARTINIS N 3RD, Lopez RN, Pickering EH, Schmidt CJ, et al
    A Proof-of-Concept Study Evaluating the Phosphodiesterase 10A Inhibitor PF-02545920 in the Adjunctive Treatment of Suboptimally Controlled Symptoms of Schizophrenia.
    J Clin Psychopharmacol. 2019 Jun 11. doi: 10.1097/JCP.0000000000001047.
    PubMed     Text format     Abstract available


    Neuropsychopharmacology

  6. LEUCHT S, Chaimani A, Mavridis D, Leucht C, et al
    Disconnection of drug-response and placebo-response in acute-phase antipsychotic drug trials on schizophrenia? Meta-regression analysis.
    Neuropsychopharmacology. 2019 Jun 18. pii: 10.1038/s41386-019-0440.
    PubMed     Text format     Abstract available


    Pharmacopsychiatry

  7. ZHENG W, Li XB, Shi ZM, Yang XH, et al
    Adjunctive Reboxetine for Schizophrenia: Meta-analysis of Randomized Double-blind, Placebo-controlled Trials.
    Pharmacopsychiatry. 2019 Jun 17. doi: 10.1055/a-0914-3260.
    PubMed     Text format     Abstract available


    Psychiatry Res

  8. VIDARSDOTTIR OG, Roberts DL, Twamley EW, Gudmundsdottir B, et al
    Integrative cognitive remediation for early psychosis: Results from a randomized controlled trial.
    Psychiatry Res. 2019;273:690-698.
    PubMed     Text format     Abstract available

  9. GALLI L, Del Grande C, Rindi L, Mangia C, et al
    Lack of circulating toxoplasma gondii DNA in seropositive patients with bipolar or schizophrenia spectrum disorders.
    Psychiatry Res. 2019;273:706-711.
    PubMed     Text format     Abstract available

  10. YOUN T, Jeong SH, Kim YS, Chung IW, et al
    Long-term clinical efficacy of maintenance electroconvulsive therapy in patients with treatment-resistant schizophrenia on clozapine.
    Psychiatry Res. 2019;273:759-766.
    PubMed     Text format     Abstract available

  11. XU C, Yang X, Sun L, Yang T, et al
    An investigation of calcium-independent phospholipase A2 (iPLA2) and cytosolic phospholipase A2 (cPLA2) in schizophrenia.
    Psychiatry Res. 2019;273:782-787.
    PubMed     Text format     Abstract available

  12. MYLLYAHO T, Siira V, Wahlberg KE, Hakko H, et al
    Interaction of genetic vulnerability to schizophrenia and family functioning in adopted-away offspring of mothers with schizophrenia.
    Psychiatry Res. 2019;278:205-212.
    PubMed     Text format     Abstract available


    Schizophr Res

  13. FERRARA M, Guloksuz S, Li F, Burke S, et al
    Parsing the impact of early detection on duration of untreated psychosis (DUP): Applying quantile regression to data from the Scandinavian TIPS study.
    Schizophr Res. 2019 Jun 13. pii: S0920-9964(19)30212.
    PubMed     Text format     Abstract available

  14. YANG K, Kondo MA, Jaaro-Peled H, Cash-Padgett T, et al
    The transcriptome landscape associated with Disrupted-in-Schizophrenia-1 locus impairment in early development and adulthood.
    Schizophr Res. 2019 Jun 13. pii: S0920-9964(19)30209.
    PubMed     Text format     Abstract available

  15. REZANSOFF SN, Moniruzzaman A, Somers JM
    Temporal associations between medication adherence for patients with schizophrenia and opioid dependence: A 17-year Canadian Cohort Study.
    Schizophr Res. 2019 Jun 12. pii: S0920-9964(19)30208.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Schizophrenia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: